APAC Acute Respiratory Distress Syndrome (ARDS) Treatment Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	189 Pages	Data Bridge Market Research	October, 2023	DAABD18360464

Best Price Guarantee
Price	from $3,500
Length	189 Pages
Publisher	Data Bridge Market Research
Published Date	October, 2023
SKU	DAABD18360464

APAC Acute Respiratory Distress Syndrome (ARDS) Treatment Market

The Asia-Pacific Acute Respiratory Distress Syndrome (ARDS) treatment is expected to reach USD 2,249,032.64 thousand by 2030, from USD 966,456.13 thousand in 2022, growing at the CAGR of 11.6% in the forecast period of 2023 to 2030.
Market Segmentation
Asia-Pacific Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type (Mechanical Ventilation, Corticosteroids, Antiviral Medication, Extracorporeal Membrane Oxygenation (ECMO), Tocilizumab, and Others), Cause ( Sepsis, Inhalation of Harmful Substances, Severe Pneumonia, and Others), Route of Administration (Parenteral, Oral, and Others), End User (Hospitals, Specialty Clinics, Home Healthcare, and Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Country Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam and Rest of Asia-Pacific Industry Trends and Forecast to 2030

Overview of Asia-Pacific Acute Respiratory Distress Syndrome (ARDS) Treatment Market Dynamics

Driver
• Increasing prevalence and incidence of acute lung injury in the market

Restraint

• High cost of device and treatment

Opportunity

• Strategic initiatives joined with new product launches by market players
Market Players
Some of the major market players operating in the Asia-Pacific Acute Respiratory Distress Syndrome (ARDS) market are listed below:
• Gilead Sciences, Inc.
• Terumo Medical Corporation
• Getinge AB.
• LivaNova PLC
• Medtronic
• ResMed
• Fisher & Paykel Healthcare Limited.
• Drägerwerk AG & Co. KGaA
• NIPRO
• Fresenius SE & Co. KGaA
• Hamilton Medical
• Pfizer Inc.
• WEINMANN Emergency Medical Technology GmbH + Co. KG
• EUROSETS
• Armstrong Medical
• nice Neotech Medical Systems Pvt. Ltd.
• Besmed Health Business Corp.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of Asia - Pacific Acute Respiratory Distress Syndrome (Ards) Market; 1.4 Limitations; 1.5 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Currency And Pricing; 2.5 Dbmr Tripod Data Validation Model; 2.6 Multivariate Modelling; 2.7 Type Lifeline Curve; 2.8 Primary Interviews With Key Opinion Leaders; 2.9 Dbmr Market Position Grid; 2.10 Market End User Coverage Grid; 2.11 Vendor Share Analysis; 2.12 Secondary Sources; 2.13 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestel Analysis; 4.2 Porter’s Five Forces; 4.3 Insurance Reimbursement; 4.3.1 Center For Medicare Services (Cms)–elso (Extracorporeal Life Support Organization); 4.3.2 Health Resources And Services Administration; 4.3.3 Abbott Coding Guide For Ecmo; 4.3.4 Central Government Health Scheme (Cghs); 4.3.5 Cern Health Insurance Scheme; 4.3.6 American Society Of Clinical Oncology (Asco) – (Medicare & Medicaid); 4.3.7 American Hospital Association; 4.4 Pipeline Analysis; 4.5 Pricing Analysis
5 Market Overview: 5.1 Drivers; 5.1.1 Increasing Prevalence And Incidence Of Acute Lung Injury; 5.1.2 Wide Range Of Risk Factors For Ards Treatment; 5.1.3 Rising Rate Of Air Pollution And Unhealthy Lifestyle; 5.1.4 Increasing Accident Rates And Trauma Causing Ards; 5.2 Restraints; 5.2.1 Complications Associated With The Treatment; 5.2.2 High Cost Of Devices And Treatment; 5.3 Opportunities; 5.3.1 Rising Healthcare Expenditure To Improve Treatment Facilities; 5.3.2 Strategic Initiatives Joined With New Product Launch By Market Players; 5.3.3 Improving Awareness Regarding Ard Syndrome; 5.4 Challenges; 5.4.1 Stringent Rules & Regulations; 5.4.2 Multiple Challenges Faced By Icu Staff
6 Asia - Pacific Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type: 6.1 Overview; 6.2 Mechanical Ventilation; 6.2.1 High-flow Nasal O2; 6.2.2 Bi-level Positive Airway Pressure; 6.2.3 Continuous Positive Airway Pressure; 6.2.4 Prone Position Ventilation; 6.2.5 Others; 6.3 Corticosteroids; 6.3.1 Methylprednisolone; 6.3.2 Dexamethasone; 6.3.3 Others; 6.4 Antiviral Medication; 6.4.1 Ribavirin; 6.4.2 Oseltamivir; 6.4.3 Others; 6.5 Extracorporeal Membrane Oxygenation (Ecmo); 6.6 Tocilizumab; 6.7 Others 70
7 Asia - Pacific Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause: 7.1 Overview; 7.2 Sepsis; 7.3 Inhalation Of Harmful Substances; 7.4 Severe Pneumonia; 7.5 Others
8 Asia - Pacific Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration: 8.1 Overview; 8.2 Parenteral; 8.2.1 Intravenous; 8.2.2 Intramuscular; 8.3 Oral; 8.4 Others
9 Asia - Pacific Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User: 9.1 Overview; 9.2 Hospitals; 9.3 Specialty Clinics; 9.4 Home Healthcare; 9.5 Others
10 Asia - Pacific Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel: 10.1 Overview; 10.2 Direct Tender; 10.3 Hospital Pharmacy; 10.4 Retail Pharmacy; 10.5 Online Pharmacy 94
11 Asia - Pacific Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region: 11.1 Asia-pacific; 11.1.1 Japan; 11.1.2 China; 11.1.3 India; 11.1.4 South Korea; 11.1.5 Australia; 11.1.6 Singapore; 11.1.7 Thailand; 11.1.8 Malaysia; 11.1.9 Indonesia; 11.1.10 Philippines; 11.1.11 Rest Of Asia-pacific
12 Asia - Pacific Acute Respiratory Distress Syndrome (Ards) Treatment Market, Company Landscape: 12.1 Company Share Analysis: Asia - Pacific
13 Swot Analysis
14 Asia - Pacific Acute Respiratory Distress Syndrome (Ards) Treatment, Cps: 14.1 Gilead Sciences Inc.; 14.1.1 Company Snapshot; 14.1.2 Revenue Analysis; 14.1.3 Company Share Analysis; 14.1.4 Product Portfolio; 14.1.5 Recent Development; 14.2 Terumo Corporation; 14.2.1 Company Snapshot; 14.2.2 Revenue Analysis; 14.2.3 Company Share Analysis; 14.2.4 Product Portfolio; 14.2.5 Recent Development; 14.3 Getinge; 14.3.1 Company Snapshot; 14.3.2 Revenue Analysis; 14.3.3 Company Share Analysis; 14.3.4 Product Portfolio; 14.3.5 Recent Development; 14.4 Livanova Plc; 14.4.1 Company Snapshot; 14.4.2 Revenue Analysis; 14.4.3 Company Share Analysis; 14.4.4 Product Portfolio; 14.4.5 Recent Developments; 14.5 Medtronic; 14.5.1 Company Snapshot; 14.5.2 Revenue Analysis; 14.5.3 Company Share Analysis; 14.5.4 Product Portfolio; 14.5.5 Recent Developments; 14.6 Armstrong Medical; 14.6.1 Company Snapshot; 14.6.2 Product Portfolio; 14.6.3 Recent Development; 14.7 Besmed Health Business Corp.; 14.7.1 Company Snapshot; 14.7.2 Product Portfolio; 14.7.3 Recent Developments; 14.8 Drägerwerk Ag & Co. Kgaa; 14.8.1 Company Snapshot; 14.8.2 Revenue Analysis; 14.8.3 Product Portfolio; 14.8.4 Recent Developments; 14.9 Eurosets; 14.9.1 Company Snapshot; 14.9.2 Product Portfolio; 14.9.3 Recent Development; 14.10 Fisher & Paykel Healthcare Limited; 14.10.1 Company Snapshot; 14.10.2 Revenue Analysis; 14.10.3 Product Portfolio; 14.10.4 Recent Developments; 14.11 Fresenius Se & Co. Kgaa.; 14.11.1 Company Snapshot; 14.11.2 Revenue Analysis; 14.11.3 Product Portfolio; 14.11.4 Recent Development; 14.12 Hamilton Medical; 14.12.1 Company Snapshot; 14.12.2 Product Portfolio; 14.12.3 Recent Development; 14.13 Nice Neotech Medical Systems Pvt.Ltd.; 14.13.1 Company Snapshot; 14.13.2 Product Portfolio; 14.13.3 Recent Development; 14.14 Nipro; 14.14.1 Company Snapshot; 14.14.2 Revenue Analysis; 14.14.3 Product Portfolio; 14.14.4 Recent Development; 14.15 Pfizer Inc.; 14.15.1 Company Snapshot; 14.15.2 Revenue Analysis; 14.15.3 Product Portfolio; 14.15.4 Recent Development; 14.16 Resmed; 14.16.1 Company Snapshot; 14.16.2 Revenue Analysis; 14.16.3 Product Portfolio; 14.16.4 Recent Development; 14.17 Weinmann Emergency Medical Technology Gmbh + Co. Kg; 14.17.1 Company Snapshot; 14.17.2 Product Portfolio; 14.17.3 Recent Development
15 Questionnaire
16 Related Reports
List Of Tables: Table 1 List Of Prices For Approved Drugs For Acute Respiratory Distress Syndrome (Ards) Treatment; Table 2 Asia - Pacific Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 3 Asia - Pacific Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 4 Asia - Pacific Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 5 Asia - Pacific Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 6 Asia - Pacific Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 7 Asia - Pacific Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 8 Asia - Pacific Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 9 Asia - Pacific Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 10 Asia - Pacific Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 11 Asia - Pacific Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 12 Asia - Pacific Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 13 Asia - Pacific Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 14 Asia - Pacific Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 15 Asia - Pacific Extracorporeal Membrane Oxygenation (Ecmo) In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 16 Asia - Pacific Tocilizumab In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 17 Asia - Pacific Others In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 18 Asia - Pacific Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand); Table 19 Asia - Pacific Sepsis In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 20 Asia - Pacific Inhalation Of Harmful Substances In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 21 Asia - Pacific Severe Pneumonia In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 22 Asia - Pacific Others In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 23 Asia - Pacific Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 24 Asia - Pacific Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 25 Asia - Pacific Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 26 Asia - Pacific Oral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 27 Asia - Pacific Others In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 28 Asia - Pacific Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 29 Asia - Pacific Hospitals In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 30 Asia - Pacific Specialty Clinics In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 31 Asia - Pacific Home Healthcare In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 32 Asia - Pacific Others In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 33 Asia - Pacific Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 34 Asia - Pacific Direct Tender In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 35 Asia - Pacific Hospital Pharmacy In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 36 Asia - Pacific Retail Pharmacy In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 37 Asia - Pacific Online Pharmacy In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 38 Asia-pacific Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Country, 2021-2030 (Usd Thousand); Table 39 Asia-pacific Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 40 Asia-pacific Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 41 Asia-pacific Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 42 Asia-pacific Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 43 Asia-pacific Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 44 Asia-pacific Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 45 Asia-pacific Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 46 Asia-pacific Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand); Table 47 Asia-pacific Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 48 Asia-pacific Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 49 Asia-pacific Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 50 Asia-pacific Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 51 Japan Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 52 Japan Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 53 Japan Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 54 Japan Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 55 Japan Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 56 Japan Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 57 Japan Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 58 Japan Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 59 Japan Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 60 Japan Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 61 Japan Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand); Table 62 Japan Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 63 Japan Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 64 Japan Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 65 Japan Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 66 China Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 67 China Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 68 China Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 69 China Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 70 China Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 71 China Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 72 China Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 73 China Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 74 China Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 75 China Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 76 China Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand); Table 77 China Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 78 China Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 79 China Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 80 China Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 81 India Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 82 India Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 83 India Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 84 India Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 85 India Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 86 India Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 87 India Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 88 India Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 89 India Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 90 India Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 91 India Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand); Table 92 India Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 93 India Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 94 India Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 95 India Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 96 South Korea Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 97 South Korea Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 98 South Korea Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 99 South Korea Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 100 South Korea Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 101 South Korea Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 102 South Korea Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 103 South Korea Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 104 South Korea Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 105 South Korea Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 106 South Korea Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand); Table 107 South Korea Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 108 South Korea Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 109 South Korea Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 110 South Korea Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 111 Australia Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 112 Australia Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 113 Australia Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 114 Australia Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 115 Australia Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 116 Australia Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 117 Australia Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 118 Australia Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 119 Australia Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 120 Australia Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 121 Australia Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand); Table 122 Australia Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 123 Australia Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 124 Australia Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 125 Australia Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 126 Singapore Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 127 Singapore Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 128 Singapore Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 129 Singapore Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 130 Singapore Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 131 Singapore Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 132 Singapore Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 133 Singapore Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 134 Singapore Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 135 Singapore Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 136 Singapore Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand); Table 137 Singapore Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 138 Singapore Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 139 Singapore Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 140 Singapore Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 141 Thailand Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 142 Thailand Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 143 Thailand Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 144 Thailand Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 145 Thailand Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 146 Thailand Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 147 Thailand Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 148 Thailand Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 149 Thailand Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)